Dupilumab in Eosinophilic Gastritis
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study ID
- NCT03678545
- Phase
- PHASE2
- Status
- Completed
Conditions
- Eosinophilic Gastritis
- Eosinophilic Gastroenteritis
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Dupilumab (blinded) — DRUGSubcutaneous injection every two weeks as follows: 600 mg initial dose, and 300 mg subsequent doses for a total of 6 injections.
- Placebo (blinded) — DRUGPlacebo is matched to the active drug (dupilumab), and is given in the same manner: a subcutaneous injection every two weeks for a total of 6 injections.
Study Details
40 participants with Eosinophilic Gastritis 12-70 years of age will be randomly assigned with dupilumab or placebo subcutaneous injections every two weeks for a total of 12 weeks. Study subjects who complete the 12-week treatment phase, may continue into an open label extension study, where dupilumab will be administered every two weeks for a total of 24 weeks.
Key Dates
- Start date
- May 15, 2021
- Status verified
- Mar 2025
- Primary completion
- Mar 4, 2024
- Completion
- Nov 13, 2024
Study Design
- Enrollment
- 41 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Dupilumab
- Placebo Comparator: Placebo
Primary Outcome Measure
Relative Change of Peak Eosinophil Counts in the Stomach [ Time Frame: 12 weeks after randomization ]
Locations (12)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital Colorado | Aurora | Colorado | 80045 | - |
| University of Colorado Denver and Hospital | Aurora | Colorado | 80045 | - |
| Northwestern Medicine Digestive Health Center | Chicago | Illinois | 60611 | - |
| Riley Children's Hospital | Indianapolis | Indiana | 46202 | - |
| Tufts Medical Center | Boston | Massachusetts | 02111 | - |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | - |
| University of North Carolina School of Medicine | Chapel Hill | North Carolina | 27599 | - |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | - |
| The Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | - |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | - |
| Texas Children's Hospital | Houston | Texas | 77030 | - |
| University of Utah Hospital | Salt Lake City | Utah | 84132 | - |
Find similar trials in Aurora, CO
Related Studies
- OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the AgesRecruiting · Children's Hospital Medical Center, Cincinnati · Phoenix, Arizona
- Eosinophilic Gastrointestinal Disorders RegistryRecruiting · Ann & Robert H Lurie Children's Hospital of Chicago · Chicago, Illinois
- Study of Gastric Motility in Eosinophilic GastritisRecruiting · Children's Hospital Medical Center, Cincinnati · Chicago, Illinois
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruiting · Sanford Health · Sioux Falls, South Dakota